Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Selectis Health (GBCS) Enterprise Value (2017 - 2025)

Selectis Health's Enterprise Value history spans 14 years, with the latest figure at -$417125.0 for Q3 2025.

  • For Q3 2025, Enterprise Value rose 50.24% year-over-year to -$417125.0; the TTM value through Sep 2025 reached -$417125.0, up 50.24%, while the annual FY2024 figure was -$680332.0, 54.17% up from the prior year.
  • Enterprise Value for Q3 2025 was -$417125.0 at Selectis Health, up from -$559983.0 in the prior quarter.
  • Across five years, Enterprise Value topped out at -$417125.0 in Q3 2025 and bottomed at -$4.0 million in Q4 2021.
  • The 5-year median for Enterprise Value is -$952195.0 (2022), against an average of -$1.6 million.
  • The largest annual shift saw Enterprise Value plummeted 487.63% in 2021 before it soared 74.44% in 2022.
  • A 5-year view of Enterprise Value shows it stood at -$4.0 million in 2021, then skyrocketed by 39.03% to -$2.4 million in 2022, then surged by 38.57% to -$1.5 million in 2023, then skyrocketed by 54.17% to -$680332.0 in 2024, then surged by 38.69% to -$417125.0 in 2025.
  • Per Business Quant, the three most recent readings for GBCS's Enterprise Value are -$417125.0 (Q3 2025), -$559983.0 (Q2 2025), and -$736919.0 (Q1 2025).